Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-25-016373
Filing Date
2025-06-03
Accepted
2025-06-03 13:25:24
Documents
1
Period of Report
2025-05-30

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 4566
  Complete submission text file 0001127602-25-016373.txt   6356
Mailing Address 126 EAST LINCOLN AVENUE P.O. BOX 2000 RAHWAY NJ 07065
Business Address 126 EAST LINCOLN AVENUE P.O. BOX 2000 RAHWAY NJ 07065 908-740-4000
Merck & Co., Inc. (Issuer) CIK: 0000310158 (see all company filings)

EIN.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1250 5TH AVENUE SOUTH NAPLES FL 34102
Business Address
THULIN INGE G (Reporting) CIK: 0001263739 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-06571 | Film No.: 251018299